RadNet Pursues $200 Million Incremental Term Loan to Support Acquisitions, Expansion and Strategic Growth
RadNet, Inc a leading provider of outpatient diagnostic imaging services and radiology technology solutions in the United States, announced plans to secure an incremental term loan totaling $200 million to strengthen its financial position and support future growth initiatives.
The proposed financing would be completed through an amendment to the company’s existing credit agreement and would serve as an addition to RadNet’s current term loan facility. If finalized, the new loan would mature on April 18, 2031, matching the maturity date of the company’s existing term loan structure.
The financing initiative reflects RadNet’s ongoing commitment to expanding its diagnostic imaging footprint, advancing healthcare technology capabilities, and pursuing strategic opportunities across its national network. Company leadership indicated that the additional capital would provide greater flexibility to execute growth strategies while maintaining momentum in key business areas.
According to RadNet, proceeds from the proposed incremental term loan are expected to be directed toward several strategic priorities, including future acquisitions, organic business expansion, health system partnerships, and general corporate purposes. These investments are intended to enhance the company’s ability to deliver diagnostic imaging services while expanding access to innovative healthcare technologies.
RadNet has continued to grow its presence across multiple markets through a combination of acquisitions, partnerships, and investments in advanced imaging technologies. The proposed financing is expected to support these efforts by providing resources that can be deployed toward both operational growth and long-term strategic initiatives.
Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, said the company is proactively exploring financing opportunities to position itself for future expansion.
“We are seeking to opportunistically and proactively raise additional funds to support the future growth of our business,” Stolper stated. “While the completion of the transaction remains subject to customary market conditions and other requirements, we expect to finalize the financing during the middle of this month if conditions remain favorable.”
The proposed transaction remains subject to standard closing conditions, market availability, and lender participation. There can be no assurance that the financing will be completed as currently contemplated or on the anticipated timeline.
By pursuing additional capital through its existing credit framework, RadNet aims to maintain financial flexibility while supporting investments across its expanding portfolio of imaging centers and digital health solutions. The company has increasingly focused on integrating technology into diagnostic imaging workflows, including artificial intelligence applications designed to improve clinical efficiency, patient outcomes, and operational performance.
Beyond its imaging center operations, RadNet has established itself as a significant player in healthcare technology through its DeepHealth platform. The company develops and markets radiology information technology solutions and artificial intelligence tools that support healthcare providers in managing imaging data, enhancing diagnostic accuracy, and streamlining clinical workflows.
The proposed financing aligns with broader trends in healthcare, where providers are investing heavily in technology-enabled care delivery, outpatient services, and strategic partnerships to meet growing patient demand. As healthcare systems continue to emphasize accessibility, efficiency, and value-based care, outpatient imaging providers such as RadNet are positioned to play an increasingly important role in diagnostic services.
RadNet currently operates one of the largest networks of freestanding outpatient imaging centers in the United States. Its presence spans key markets including Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas, and Virginia. Through its extensive network, the company provides a wide range of imaging services designed to support physicians, healthcare systems, and patients.
In addition to imaging center operations, RadNet offers teleradiology services, radiology technology platforms, and related healthcare solutions to customers worldwide. The company’s workforce, including contracted radiologists, full-time employees, technologists, and per diem professionals, exceeds 11,000 team members.
The planned $200 million incremental term loan represents another step in RadNet’s long-term growth strategy as it continues expanding its national footprint, strengthening technology capabilities, and pursuing opportunities that support sustainable business growth. If completed, the financing would provide the company with additional resources to capitalize on emerging opportunities in diagnostic imaging, digital health, and healthcare partnerships while reinforcing its position as a leader in the evolving medical imaging industry.
About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet’s imaging center markets include Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under its DeepHealth brand and teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members
